Lewes, DE -- (SBWIRE) -- 01/18/2019 -- Global Allergy Immunotherapies (Allergy Immunotherapy) market will register a 8.3% CAGR in terms of revenue, reach US$ 1730 million by 2023, from US$ 1070 million in 2017.

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

The classification of Allergy Immunotherapy includes Subcutaneous Immunotherapy and Sublingual Immunotherapy. The proportion of Subcutaneous Immunotherapy in 2017 is about 55.1%, and the proportion of Sublingual Immunotherapy in 2016 is about 44.9%.

Allergy Immunotherapy are application in Allergic Rhinitis, Allergic Asthma and Other. The most of Allergy Immunotherapy is used in Allergic Rhinitis, and the market share of that is about 45.3 % in 2017.

Over the next five years, study projects that Allergy Immunotherapies (Allergy Immunotherapy) will register a 8.3% CAGR in terms of revenue, reach US$ 1730 million by 2023, from US$ 1070 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Allergy Immunotherapies (Allergy Immunotherapy) market by product type, application, key manufacturers and key regions.

To calculate the market size, study considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Subcutaneous Immunotherapy
Sublingual Immunotherapy

Segmentation by application:
Allergic Rhinitis
Allergic Asthma
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Allergy Immunotherapies (Allergy Immunotherapy) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Allergy Immunotherapies (Allergy Immunotherapy) market by identifying its various subsegments.
Focuses on the key global Allergy Immunotherapies (Allergy Immunotherapy) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Allergy Immunotherapies (Allergy Immunotherapy) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Allergy Immunotherapies (Allergy Immunotherapy) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Spanning over 136 pages "Forecast of Global Allergy Immunotherapies (Allergy Immunotherapy) Consumption Market 2023" report covers Scope of the Report, Executive Summary, Global Allergy Immunotherapies (Allergy Immunotherapy) by Players, Allergy Immunotherapies (Allergy Immunotherapy) by Regions, Market Drivers, Challenges and Trends, Marketing, Distributors and Customer, Global Allergy Immunotherapies (Allergy Immunotherapy) Market Forecast, Key Players Analysis, Research Findings and Conclusion.

Please visit this link for more details: https://www.marketresearchreports.com/mrrpb2/forecast-global-allergy-immunotherapies-allergy-immunotherapy-consumption-market-2023

Find all Healthcare Reports at: https://www.marketresearchreports.com/healthcare

For related reports please visit: https://www.marketresearchreports.com/search/site/Allergy%2520Immunotherapy

Read our Interactive Market Research Blog

About MarketResearchReports.com
MarketResearchReports.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Contact us for your market research requirements: https://www.marketresearchreports.com/contact